Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases
ACTIVE_NOT_RECRUITING
Status
Conditions
- Autoimmune Disease
- Neurologic Autoimmune Disease
- Autologous Transplant Autoimmune
- Multiple Sclerosis Transplant
- MS Stem Cell Transplant
- Multiple Sclerosis Stem Cell Transplant
- Stiff Person Syndrome
- HCT for Neurologic Autoimmune Disorders
- CIDP Transplant
- Myasthenia Gravis Transplant
- Autoimmune Nervous System Disorder
- Central Nervous System Vasculitis
- Cerebellar Degeneration
- Chronic Inflammatory Demyelinating Polyneuropathy
- Lambert Eaton Myasthenic Syndrome
- Myasthenia Gravis
- Neuromyelitis Optica
- Opsoclonus Myoclonus Syndrome
- Rasmussen Subacute Encephalitis
Interventions
- BIOLOGICAL: Anti-Thymocyte Globulin
- PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation
- DRUG: Carmustine
- DRUG: Cytarabine
- DRUG: Etoposide
- OTHER: Laboratory Biomarker Analysis
- DRUG: Melphalan
- PROCEDURE: Peripheral Blood Stem Cell Transplantation
- DRUG: Prednisone
- PROCEDURE: Syngeneic Bone Marrow Transplantation
Sponsor
Fred Hutchinson Cancer Center